In the landscape of oncology, the dissemination of cancerous cells to distant body sites—a process known as metastasis—is a common, yet complex, phenomenon that physicians must navigate when determining the best course of treatment for patients. Renal cell carcinoma (RCC), a type of kidney cancer, is known for its potential to metastasize to various regions of the body; however, certain sites are more commonly affected than others. In a seminal case reported in the Journal of Nippon Medical School, researchers presented the first known case of synchronous cystic duct metastasis from RCC in a 72-year-old female patient (Ueda et al., 2019).
This rare case drew attention as metastasis to the cystic duct, a channel connecting the gallbladder to the common bile duct, is a highly infrequent event with only one previously reported metachronous case—when metastasis is diagnosed at a different time than the primary tumor. This exceptional case report was published with a DOI of 10.1272/jnms.JNMS.2018_86-405 and can be retrieved from the National Center for Biotechnology Information (NCBI) database using the PubMed Unique Identifier (PMID): 31061254.
Case Summary
The patient in question presented with hematuria, which is the presence of blood in urine, and on further investigation via enhanced computed tomography (CT) of the abdomen, a mass in the left kidney was identified. This tumor, measuring 5.8 × 3.0 cm, showed characteristic imaging features of RCC, with strong enhancement in the early phase of imaging and a washout pattern in the late phase. Additionally, the CT scan revealed a mass of 2 cm in the left adrenal gland, a 1.0-cm mass in the right adrenal gland, and multiple tiny masses in the cystic duct.
Following these findings, the patient was diagnosed with left RCC, cystic duct metastasis, and bilateral adrenal gland metastases. Given the proximity of the metastatic tumor to the common bile duct, the medical team proceeded with an aggressive surgical approach. The patient underwent a left nephrectomy to remove the affected kidney, bilateral adrenalectomy, cholecystectomy to remove the gallbladder, resection of the extrahepatic bile duct, and hepaticojejunostomy—an operation creating a connection between the liver and jejunum—to ensure bile from the liver could still reach the small intestine post-removal of bile duct sections.
Pathological examinations confirmed that the primary renal tumor and metastases in the adrenal glands and cystic duct were all clear cell carcinoma, a subtype of RCC. Tragically, the patient succumbed to the disease 30 months following the complex surgical procedures.
Discussion
This case underscores the unpredictable nature of RCC metastasis. While the lung, bone, liver, brain, and adrenal glands are familiar sites of RCC metastasis, this report expands the understanding of potential metastatic progressions by documenting a synchronous cystic duct metastasis.
The rarity of cystic duct involvement is highlighted in the literature with a scarcity of similar cases, underscoring the importance of this particular patient example. This distinct case suggests that a wider spread of diagnostic attention during RCC workup may be warranted to identify less common metastatic sites.
Clinical Implications
This singular case highlights several critical points for clinicians. Firstly, the necessity for comprehensive imaging in the staging and monitoring of RCC to ensure accurate diagnosis and the planning of appropriate treatment regimens. Secondly, the case calls attention to the possible need for radical surgical treatment to address widespread metastasis.
Follow-up and Outcomes
Postoperative follow-up for the patient involved in this case was critical given the aggressive nature of the disease and the treatment. Although the patient succumbed to her illness 30 months later, the surgical interventions were crucial for palliative reasons, potentially extending the quality and duration of life.
Conclusion
This case contributes a novel aspect to the medical understanding of RCC metastasis, expanding the scope of known metastatic sites to include the cystic duct. The complex therapeutic choices faced by the surgical team in this instance also provide a significant reference point that may inform future treatment strategies for similarly situated patients with advanced RCC.
Keywords
1. Cystic duct metastasis
2. Renal cell carcinoma metastasis
3. RCC surgical treatment
4. Rare cancer metastasis
5. Kidney cancer metastatic spread
References:
1. Ueda, J., Makino, H., Yokoyama, T., Maruyama, H., Hirakata, A., Takata, H., Seki, N., Kikuchi, Y., Yoshioka, M., & Irie, T. (2019). Rare Case of Synchronous Cystic Duct Metastasis from Renal Cell Carcinoma. Journal of Nippon Medical School, 86(4), 242–247. https://doi.org/10.1272/jnms.JNMS.2018_86-405
2. Motzer, R. J., Bander, N. H., & Nanus, D. M. (1996). Renal-Cell Carcinoma. New England Journal of Medicine, 335(12), 865–875.
3. Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., & Charbonneau, C. (2008). Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treatment Reviews, 34(3), 193–205.
4. Capitanio, U., & Montorsi, F. (2016). Renal cancer. The Lancet, 387(10021), 894–906.
5. Ljungberg, B., Bensalah, K., Canfield, S., Dabestani, S., Hofmann, F., Hora, M., … & Powles, T. (2015). EAU guidelines on renal cell carcinoma: 2014 update. European Urology, 67(5), 913–924.